Selkirk Management LLC Accelerate Diagnostics, Inc Transaction History

Selkirk Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.27 - $6.97 $1.12 Million - $1.83 Million	-261,993 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.81 - $9.23 $182,589 - $247,474	-26,812 Reduced 9.28%	261,993 $2.11 Million
Q1 2021 May 17, 2021	SELL	$7.99 - $15.0 $479,400 - $900,000	-60,000 Reduced 17.2%	288,805 $2.4 Million
Q4 2018 Feb 14, 2019	BUY	$10.42 - $21.94 $76,639 - $161,368	7,355 Added 2.15%	348,805 $4.01 Million
Q2 2018 Aug 14, 2018	SELL	$19.02 - $24.95 $382,302 - $501,495	-20,100 Reduced 5.56%	341,450 $7.61 Million
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $1.41 Million - $2.35 Million	-78,450 Reduced 17.83%	361,550 $9.47 Million
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $9.28 Million - $11.1 Million	440,000	440,000 $9.88 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $146M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Selkirk Management LLC, based on Form 13F filings with the SEC.

Stay updated on Selkirk Management LLC with notifications on news.